Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Empowering patients through telehealth

October 25, 2010 Sales and Marketing George MacGinnis, Henry Rivera, Michael Dillon, NHS telehealth, Whole System Demonstrators, diabetes telehealth, pa consulting, patients, telehealth

Current models of healthcare are becoming unsustainable all over the world, due to people living longer with chronic diseases, and …
Feature

FDA rejects Viropharma’s Cinryze manufacturing expansion

October 25, 2010 Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing

ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
News
GlaxoSmitKline's headquarters

Revenue slump for GSK as Avandia sales stall

October 22, 2010 Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results

GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …
News

Lilly suspends late-stage trials of diabetes drug Protege

October 22, 2010 Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes

Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …
News

Anna Protopapas to lead Takeda’s global business development unit

October 21, 2010 Sales and Marketing Anna Protopapas, Japanese pharma company, Takeda, appointment, sales and marketing

Takeda has set up a new global business development unit within its US subsidiary to oversee mergers, acquisitions and other …
Appointment

Novartis posts strong Q3 results

October 21, 2010 Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales

Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …
News

FDA approves Boehringer’s Pradaxa

October 20, 2010 Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …
News

FDA warns of bisphosphonates fracture risk

October 20, 2010 Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis

The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …
News
Pharma association the ABPI

NICE needs narrower focus, says ABPI

October 20, 2010 Sales and Marketing ABPI, NICE, value

NICE’s remit should be changed to give it a greater focus on the value of innovation, according to UK pharma …
News

Apixaban trial for ACS abandoned

October 20, 2010 Sales and Marketing ACS, BMS, Pfizer, apixaban

  Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …
News
Dr Ben Goldacre

Dr Ben Goldacre: “This is a very broken system”

October 19, 2010 Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data

The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …
Feature

Trial shows long-term benefits of Novartis’ Aclasta

October 18, 2010 Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …
News
2fe094c

IDEA Pharma appoints Tony Akiwumi

October 18, 2010 Sales and Marketing Go-To-Market Strategy, IDEA Pharma, IDEAtion, Phase II, appointment, sales and marketing

Tony Akiwumi has joined Idea Pharma as director of client value, moving to the strategic marketing consultancy from Quintiles.He will lead …
Appointment

In with the ‘new’: A leaner, fitter biosciences sector – 2010

October 18, 2010 Sales and Marketing Kinapse, White paper

The biosciences sector has witnessed numerous challenges during recent years, as the global economic downturn has adversely impacted sector liquidity …
Feature
White paper
Images of a normal brain and an Alzheimer's brain

Alzheimer’s disease

October 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Feature
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026